Predicate |
Object |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-92 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39541 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2818 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28 |
filingDate |
2016-07-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2021-12-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2021-12-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CN-108025051-B |
titleOfInvention |
Combination therapy containing anti-PD-1 antibody molecules |
abstract |
Combination therapies comprising antibody molecules that specifically bind PD-1 are disclosed. The combination therapy can be used to treat or prevent cancerous or infectious diseases and conditions. |
priorityDate |
2015-07-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |